At the Life Sciences Investor blog (www.paulmieyal.com), I cover a range of topics relating to investments in biotechnology, medical devices, diagnostics, and emerging science. Within this scope, I profile specific companies, comment on transactions and trends, and incorporate conversations with senior executives and other industry players.